The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
South African energy project finance specialist estimates that the country’s near-term battery energy storage project pipeline could grow to about R53-billion over the coming three years, potentially making the country one of the largest adopters of such systems globally.
Flawless balance sheet and undervalued
BMN has a strong track record of performance. In the previous year, BMN delivered an impressive double-digit return of 31%. Not surprisingly, BMN outperformed its industry which returned 13%, giving us more conviction of the company’s capacity to drive bottom-line growth going forward. BMN’s ability to maintain an adequate level of cash to meet upcoming liabilities is a good sign for its financial health. This implies that BMN manages its cash and cost levels well, which is an important determinant of the company’s health. Investors should not worry about BMN’s debt levels because the company has none! This means it is running its business only on equity capital funding, which is typically normal for a small-cap company. Therefore the company has plenty of headroom to grow, and the ability to raise debt should it need to in the future.
Good time to invest in South Africa & be listed on JSE Morgan Stanley statement.
https://www.bloomberg.com/news/articles/2019-03-14/morgan-stanley-says-it-s-time-for-a-bet-on-south-african-stocks?srnd=premium-europe